Trial intelligence / Profile preview

Esketamine plus ciprofol sedation for painless gastrointestinal endoscopy in elderly patients

ChiCTR2300073113Phase 4Not yet recruiting

Sponsor
The Affiliated Hospital of Xuzhou Medical University
Start
Nov 2022
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine and ciprofol (4 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Incidence of intraoperative hypotension. Planned start Nov 2022; status: not yet recruiting.

02

Drugs

esketamineciprofol

Beyond the preview

Go deeper on ChiCTR2300073113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300073113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call